BiotechTube
Home/Aardvark Therapeutics/Susan E. Graf, RPh, MBA
SE

Susan E. Graf, RPh, MBA

Board Member (Independent Director)

Aardvark Therapeutics

Therapeutic Areas

Metabolic DiseasesRare DiseasesObesity

Aardvark Therapeutics Pipeline

DrugIndicationPhase
ARD-101Prader-Willi Syndrome (hyperphagia)Phase 3

Leadership Team at Aardvark Therapeutics

TL
Tien Lee, M.D.
Chief Executive Officer
RD
Roy D. Baynes, M.D., Ph.D.
Board Member (Independent Director)
View full Aardvark Therapeutics profile